Literature DB >> 7919152

Role of adenosine in dialysis-induced hypotension.

T Shinzato1, M Miwa, S Nakai, H Morita, H Odani, I Inoue, K Maeda.   

Abstract

First, this investigation showed that plasma levels of inosine, hypoxanthine, and xanthine, which are metabolites of adenosine, rose sharply when blood pressure dropped suddenly along with symptoms during a hemodialysis session (sudden hypotension), but not when it decreased gradually with eventual symptoms (gradual hypotension). Because adenosine has an action to dilate vessels, this result indicates the possibility that the increased release of adenosine would be a cause of sudden hypotension. Second, it was found that the frequency of sudden hypotension decreases with the administration of caffeine, which is an adenosine-receptor antagonist, whereas the frequency of gradual hypotension did not change. This result supports the above-mentioned hypothesis that adenosine may well be a mediator of sudden hypotension, but not of gradual hypotension. Third, our investigation demonstrated no significant differences in plasma norepinephrine level, in plasma renin activity, or in mean blood pressure between the hemodialysis session in which caffeine was administered and the session in which a placebo was given. These findings suggest that the effect of caffeine administration to prevent sudden hypotension is not mediated by the stimulation of the sympathetic nervous system or activation of the renin-angiotensin system, but by the adenosine-receptor antagonism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7919152     DOI: 10.1681/ASN.V4121987

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  7 in total

1.  Efficacy of biventricular pacing for dialysis-related hypotension due to idiopathic dilated cardiomyopathy.

Authors:  Tetsuro Kusaba; Syuji Tanda; Hisako Kameyama; Keiichi Tamagaki; Mitsuhiko Okigaki; Tsuguru Hatta; Yoko Suzaki; Takeshi Shirayama; Hiroaki Matsubara; Susumu Sasaki
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

Review 2.  Intradialytic hypotension.

Authors:  Wesley Hayes; Daljit K Hothi
Journal:  Pediatr Nephrol       Date:  2010-10-22       Impact factor: 3.714

3.  Impact of extracorporeal blood flow rate on blood pressure, pulse rate and cardiac output during haemodialysis.

Authors:  Philip Andreas Schytz; Maria Lerche Mace; Anne Merete Boas Soja; Brian Nilsson; Nikolaos Karamperis; Bent Kristensen; Søren Daustrand Ladefoged; Henrik Post Hansen
Journal:  Nephrol Dial Transplant       Date:  2015-09-01       Impact factor: 5.992

Review 4.  Mechanisms, Clinical Implications, and Treatment of Intradialytic Hypotension.

Authors:  Patrick B Reeves; Finnian R Mc Causland
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-26       Impact factor: 8.237

5.  Safety, Pharmacokinetic, and Pharmacodynamic Study of a Sublingual Formula for the Treatment of Vasovagal Syncope.

Authors:  Paul Hutson; Regis Guieu; Jean-Claude Deharo; Pierre Michelet; Michele Brignole; Cassondra Vander Ark; Mohamed H Hamdan
Journal:  Drugs R D       Date:  2022-02-12

Review 6.  Vasopressin and prevention of hypotension during hemodialysis.

Authors:  Seyed Seifollah Beladi Mousavi; Mohamad Reza Tamadon
Journal:  Iran Red Crescent Med J       Date:  2014-11-05       Impact factor: 0.611

7.  Feasibility of intermittent back-filtrate infusion hemodiafiltration to reduce intradialytic hypotension in patients with cardiovascular instability: a pilot study.

Authors:  Yutaka Koda; Ikuo Aoike; Shin Hasegawa; Yutaka Osawa; Yoichi Nakagawa; Fumio Iwabuchi; Chikara Iwahashi; Tokuichiro Sugimoto; Toshihiko Kikutani
Journal:  Clin Exp Nephrol       Date:  2016-04-28       Impact factor: 2.801

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.